Align Technology, Inc.
IndexS&P 500 P/E29.32 EPS (ttm)7.80 Insider Own0.30% Shs Outstand78.39M Perf Week7.88%
Market Cap18.21B Forward P/E22.16 EPS next Y10.32 Insider Trans3.33% Shs Float73.16M Perf Month-4.26%
Income619.00M PEG0.68 EPS next Q2.43 Inst Own91.00% Short Float2.83% Perf Quarter-11.87%
Sales3.99B P/S4.56 EPS this Y-56.80% Inst Trans1.92% Short Ratio2.42 Perf Half Y-47.62%
Book/sh45.91 P/B4.98 EPS next Y20.66% ROA10.60% Target Price339.20 Perf Year-64.72%
Cash/sh11.30 P/C20.24 EPS next 5Y43.25% ROE17.20% 52W Range204.32 - 713.33 Perf YTD-65.18%
Dividend- P/FCF46.86 EPS past 5Y33.00% ROI21.50% 52W High-67.92% Beta1.79
Dividend %- Quick Ratio1.10 Sales past 5Y29.60% Gross Margin72.60% 52W Low11.99% ATR11.66
Employees22540 Current Ratio1.30 Sales Q/Q-4.10% Oper. Margin21.80% RSI (14)46.07 Volatility4.59% 4.67%
OptionableYes Debt/Eq0.00 EPS Q/Q-42.70% Profit Margin15.50% Rel Volume0.69 Prev Close229.91
ShortableYes LT Debt/Eq0.00 EarningsJul 27 AMC Payout0.00% Avg Volume857.09K Price228.81
Recom2.20 SMA20-2.34% SMA50-10.62% SMA200-36.94% Volume587,711 Change-0.48%
Jul-28-22Downgrade Goldman Buy → Sell $380 → $250
Jan-31-22Upgrade UBS Neutral → Buy $880 → $620
Jan-31-22Initiated Morgan Stanley Overweight $575
Oct-01-21Resumed Credit Suisse Outperform $732
Aug-05-21Resumed Credit Suisse Outperform $732
Jul-09-21Upgrade Stephens Equal-Weight → Overweight $600 → $700
Jul-08-21Initiated Exane BNP Paribas Outperform $790
Apr-22-21Upgrade Berenberg Hold → Buy $683
Jan-04-21Upgrade Evercore ISI In-line → Outperform $625
Jul-29-20Downgrade Berenberg Buy → Hold $306
Jul-20-20Downgrade BofA Securities Neutral → Underperform $280
Jan-09-20Upgrade Wolfe Research Peer Perform → Outperform
Oct-24-19Reiterated BofA/Merrill Neutral $220 → $240
Oct-07-19Downgrade Guggenheim Buy → Neutral
Jul-25-19Downgrade Evercore ISI Outperform → In-line $340 → $220
May-30-19Initiated Wolfe Research Peer Perform
Apr-18-19Initiated Guggenheim Buy
Feb-14-19Downgrade UBS Buy → Neutral $275
Jan-17-19Initiated UBS Buy $230
Nov-20-18Reiterated Credit Suisse Outperform $375 → $343
Oct-03-22 05:10PM
Sep-29-22 11:11AM
Sep-28-22 04:10PM
Sep-26-22 10:23AM
10:30AM Loading…
Sep-15-22 10:30AM
Sep-09-22 06:50AM
Sep-08-22 12:58PM
Sep-07-22 05:09PM
Sep-06-22 04:24PM
Sep-01-22 06:00PM
Aug-27-22 02:02AM
Aug-25-22 12:12PM
08:30AM Loading…
Aug-24-22 08:30AM
Aug-11-22 11:27AM
Aug-07-22 08:43PM
Aug-04-22 08:23AM
Jul-28-22 10:35AM
Jul-27-22 09:30PM
Jul-26-22 08:41AM
Jul-25-22 11:40AM
Jul-20-22 10:02AM
09:37AM Loading…
Jul-18-22 06:15PM
Jul-14-22 07:40PM
Jul-12-22 06:15PM
Jul-08-22 11:40AM
Jul-06-22 06:15PM
Jul-05-22 08:30AM
Jun-29-22 06:15PM
Jun-27-22 09:13AM
Jun-22-22 04:00PM
Jun-21-22 06:00PM
Jun-14-22 10:09AM
Jun-13-22 11:50AM
Jun-10-22 04:30PM
Jun-09-22 05:46PM
Jun-08-22 11:30AM
Jun-06-22 06:00PM
Jun-04-22 07:47AM
May-27-22 11:40AM
May-26-22 06:30AM
May-25-22 04:01PM
May-23-22 11:20AM
May-20-22 04:00PM
May-19-22 04:41PM
May-18-22 08:48AM
May-11-22 08:08AM
May-04-22 10:15AM
May-03-22 05:52AM
May-02-22 04:39PM
Apr-28-22 07:31PM
Apr-27-22 05:15PM
Apr-26-22 10:09AM
Apr-25-22 12:10PM
Apr-21-22 09:05AM
Apr-20-22 03:01PM
Apr-14-22 06:00PM
Apr-13-22 01:25PM
Apr-05-22 08:30AM
Mar-31-22 06:00PM
Mar-29-22 08:59AM
Mar-26-22 10:00AM
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Coletti Julie AnnEVP, Chief Legal & RegulatoryJul 20Option Exercise0.0070601,275Jul 22 04:15 PM
Thaler Warren SDirectorMay 18Option Exercise0.00524029,616May 19 06:12 PM
SIEGEL SUSAN EDirectorMay 18Option Exercise0.0052405,687May 19 06:11 PM
SANTORA GREG JDirectorMay 18Option Exercise0.00524010,873May 19 06:09 PM
Saia Andrea LynnDirectorMay 18Option Exercise0.00524012,282May 19 06:07 PM
Myong AnneDirectorMay 18Option Exercise0.0052403,294May 19 06:05 PM
MORROW GEORGE JDirectorMay 18Option Exercise0.00524013,273May 19 06:03 PM
LARKIN C RAYMOND JRDirectorMay 18Option Exercise0.00699018,889May 19 06:01 PM
LACOB JOSEPHDirectorMay 18Option Exercise0.005240155,880May 19 05:59 PM
Dallas Kevin JDirectorMay 18Option Exercise0.0052404,132May 19 05:57 PM
LARKIN C RAYMOND JRDirectorMay 13Buy264.421,000264,42018,190May 13 05:33 PM
HOGAN JOSEPH MPresident and CEOMay 04Buy298.486,7001,999,842174,801May 05 07:12 PM
Wright EmoryEVP, Global OperationsFeb 20Option Exercise0.0010,813010,813Feb 24 07:11 PM
Morici JohnEVP & Chief Financial OfficerFeb 20Option Exercise0.0012,183013,045Feb 24 07:10 PM
HOGAN JOSEPH MPresident and CEOFeb 20Option Exercise0.0059,8360194,976Feb 24 07:08 PM
Hockridge Stuart AEVP Global HRFeb 20Option Exercise0.009,403010,552Feb 24 07:06 PM
Coletti Julie AnnEVP, Chief Legal & RegulatoryFeb 20Option Exercise0.009270970Feb 24 07:05 PM
Hockridge Stuart ASVP Global HRDec 27Option Exercise0.001,19901,756Dec 28 05:25 PM
Thaler Warren SDirectorNov 10Sale703.065,0003,515,29446,378Nov 12 08:23 PM
Morici JohnChief Financial OfficerNov 08Sale699.083,0002,097,240827Nov 09 06:01 PM